Zymeworks (ZYME) Cash & Current Investments (2021 - 2026)

Zymeworks has disclosed Cash & Current Investments across 6 years of filings, most recently posting $364.7 million for Q1 2026.

• Cash & Current Investments for Q1 2026 came in at $364.7 million, up 37.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $364.7 million (up 37.48% YoY), and the FY2025 annual result was $228.8 million, up 1.34% from the prior year.
• Cash & Current Investments came in at $364.7 million for Q1 2026 at Zymeworks, up from $228.8 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $492.2 million in Q4 2022 to a low of $166.2 million in Q3 2022.
• The 5-year median for Cash & Current Investments is $297.2 million (2024), against an average of $306.6 million.
• Across the five-year window, Cash & Current Investments jumped 94.86% in 2022 and plunged 39.68% in 2024, its largest moves.
• Zymeworks' Cash & Current Investments stood at $492.2 million in 2022, then fell by 23.95% to $374.3 million in 2023, then slumped by 39.68% to $225.8 million in 2024, then advanced by 1.34% to $228.8 million in 2025, then surged by 59.41% to $364.7 million in 2026.
• The last three Cash & Current Investments figures came in at $364.7 million (Q1 2026), $228.8 million (Q4 2025), and $251.9 million (Q3 2025), per Business Quant data.